Dr. Maha Gashlan is a distinguished pediatric neurologist with 25 years of experience, specializing in epilepsy, headaches, neurodevelopmental disorders, and neonatal neurology. She obtained her medical degree from King Abdulaziz University and completed her fellowship in pediatric neurology at the University of Ottawa. A respected member of the American Academy of Neurology and the American Epilepsy Society, Dr. Gashlan has contributed to numerous research studies in pediatric epilepsy and neuromuscular disease, advancing the field with her insights and expertise.
Her patient care philosophy centers on providing comprehensive, compassionate care for children and their families, with a strong dedication to improving patient outcomes. Dr. Gashlan is particularly praised for her empathetic approach and her commitment to educating and empowering families about neurological health. In addition to her clinical work, she actively participates in community outreach programs and health awareness initiatives, promoting education and support for pediatric neurological conditions.
Areas of expertise.
Education and training.
- 01Pediatric Neurology Fellowship - University of Ottawa (1996 - 1999)
- 02Assitant in General Pediatrics - King Khalid National Guard Hospital Jeddah (1991 - 1995)
- 03Residency Training Program in Pediatrics - King Abdulaziz University (1986 - 1990)
- 04College of Medicine - King Abdulaziz University (1978 - 1983)
Boards and fellowships.
- 01Fellowship in Pediatric Neurology, 1999
- 02Arab Board Certification in General Pediatrics, 1991
Selected publications.
- 01Ahmad, Mushtaha, et al. "Safety and effectiveness of ataluren in patients with Duchenne muscular dystrophy: single-center experience from Saudi Arabia." Journal of International Medical Research 52.12 (2024): 03000605241305252.
- 02Diaz, Jorge, et al. "YIF1B mutations cause a post-natal neurodevelopmental syndrome associated with Golgi and primary cilium alterations." Brain 143.10 (2020): 2911-2928.
- 03Gashlan, Maha, et al. "Predictors of seizure outcome following cortical resection in pediatric and adolescent patients with medically refractory epilepsy." Child's Nervous System 15 (1999): 45-50.
- 04Singh, B., et al. "Reading-induced absence seizures." Neurology 45.8 (1995): 1623-1624.
- 05Ahmad, Mushtaha, et al. “Safety and effectiveness of ataluren in patients with Duchenne muscular dystrophy: single-center experience from Saudi Arabia.” Journal of International Medical Research 52.12 (2024): 03000605241305252.